Genome editing in sea urchin embryos by using a CRISPR/Cas9 system  by Lin, Che-Yi & Su, Yi-Hsien
Developmental Biology 409 (2016) 420–428Contents lists available at ScienceDirectDevelopmental Biologyhttp://d
0012-16
n Corr
E-mjournal homepage: www.elsevier.com/locate/developmentalbiologyTechnical NoteGenome editing in sea urchin embryos by using a CRISPR/Cas9 system
Che-Yi Lin, Yi-Hsien Su n
Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 11529, Taiwana r t i c l e i n f o
Article history:
Received 29 July 2015
Received in revised form
20 November 2015
Accepted 22 November 2015
Available online 26 November 2015
Keywords:
CRISPR/Cas9
Sea urchin
Nodalx.doi.org/10.1016/j.ydbio.2015.11.018
06/& 2015 Elsevier Inc. All rights reserved.
esponding author.
ail address: yhsu@gate.sinica.edu.tw (Y.-H. Sua b s t r a c t
Sea urchin embryos are a useful model system for investigating early developmental processes and the
underlying gene regulatory networks. Most functional studies using sea urchin embryos rely on anti-
sense morpholino oligonucleotides to knockdown gene functions. However, major concerns related to
this technique include off-target effects, variations in morpholino efﬁciency, and potential morpholino
toxicity; furthermore, such problems are difﬁcult to discern. Recent advances in genome editing tech-
nologies have introduced the prospect of not only generating sequence-speciﬁc knockouts, but also
providing genome-engineering applications. Two genome editing tools, zinc-ﬁnger nuclease (ZFN) and
transcription activator-like effector nucleases (TALENs), have been utilized in sea urchin embryos, but the
resulting efﬁciencies are far from satisfactory. The CRISPR (clustered regularly interspaced short palin-
dromic repeat)-Cas9 (CRISPR-associated nuclease 9) system serves as an easy and efﬁcient method with
which to edit the genomes of several established and emerging model organisms in the ﬁeld of devel-
opmental biology. Here, we apply the CRISPR/Cas9 system to the sea urchin embryo. We designed six
guide RNAs (gRNAs) against the well-studied nodal gene and discovered that ﬁve of the gRNAs induced
the expected phenotype in 60–80% of the injected embryos. In addition, we developed a simple method
for isolating genomic DNA from individual embryos, enabling phenotype to be precisely linked to gen-
otype, and revealed that the mutation rates were 67–100% among the sequenced clones. Of the two
potential off-target sites we examined, no off-target effects were observed. The detailed procedures
described herein promise to accelerate the usage of CRISPR/Cas9 system for genome editing in sea urchin
embryos.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
In recent years, a series of genome editing tools have been
developed, including zinc-ﬁnger nuclease (ZFN), transcription ac-
tivator-like effector nucleases (TALENs), and clustered regularly
interspaced short palindromic repeats and CRISPR-associated
protein (CRISPR/Cas9) (Gaj et al., 2013). These tools enable devel-
opmental biologists to perform various experiments involved in
modifying genomes at a precise position such as generating loss-
of-function mutations, which previously could only be obtained
through random mutagenesis. Unlike ZFN and TALENs, which use
protein domains to recognize the target genome sequences, the
CRISPR/Cas9 system recognizes targets using a short stretch of
RNA, which increases the ease of experimental manipulation.
The type II prokaryotic CRISPR/Cas9 system, which is derived
from the protection system of the gram-positive bacterium
Streptococcus pyogenes, is the most commonly used RNA-Guided
Endonucleases. It has been successfully used in several established).model organisms, such as mouse (Shen et al., 2013), zebraﬁsh
(Hwang et al., 2013), Drosophila (Bassett et al., 2013), Xenopus
(Blitz et al., 2013), and Ciona (Sasaki et al., 2014), and also in cell
lines (Mali et al., 2013). The technology also provides an easy way
to modify the genomes of several emerging model systems (Har-
rison et al., 2014). A modiﬁed CRISPR/Cas9 system composed of a
Cas9 endonuclease and a combined non-coding guide RNA (gRNA)
was recently described (Mali et al., 2013). The gRNA is composed
of two parts: the 5′ end is a CRISPR RNA (crRNA) for the re-
cognition of the target sequence, and the 3′ end is a trans-acti-
vating crRNA (tracrRNA) that enables interaction with Cas9 to
activate the endonuclease activity. After the gRNA and Cas9 are
introduced into cells, they form a complex that scans the genome
for the protospacer adjacent motif (PAM), which is NGG for the
type II CRISPR/Cas9 system. When a PAM site is recognized, the
adjacent DNA is unwound to enable the formation of the gRNA-
DNA heteroduplex through the sequence complementary me-
chanism. The complex is subsequently cleaved 3-bp upstream of
the PAM site by the Cas9 endonuclease, and a double-stranded
break (DSB) is formed (Barrangou, 2014; Ran et al., 2015; Sternberg
et al., 2014). The DSB is then repaired via non-homologous end
joining (NHEJ) or homology-directed repair (HDR). NHEJ repairs
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or deletion (indel) around the broken site.
Several modiﬁed CRISPR/Cas9 systems have been generated to
improve efﬁciency or broaden their applications. To increase
cleavage efﬁciencies, Cas9 containing a nucleus localization signal
(NLS) and gRNAs with GGAUC residues at the 3′ end are used in
the zebraﬁsh system (Jao et al., 2013). The corresponding pheno-
type found in the F0 embryos indicates that the injected embryos
have undergone the biallelic genome editing. A nanos-driven
CRISPR/Cas9 and a modiﬁed Cas9 fused with 3′UTR of nanos have
been used in the ﬂy and zebraﬁsh, respectively, allowing the
editing events occurring in germ cells thus with higher possibility
to be inherited (Kondo and Ueda, 2013; Moreno-Mateos et al.,
2015). For gene knock-out experiments, when the DSB occurs in a
coding region, the repair mechanism often leads to frameshift and
a resulting decrease in gene function. For knock-in applications,
providing a donor template, either a DNA plasmid or a single-
stranded DNA fragment, exogenous DNA can be precisely in-
tegrated into a target genomic locus via HDR to create transgenic
animals (Han et al., 2015; Hisano et al., 2015). A mutation allele
can also be replaced by introducing a correct repair template to
conduct gene therapy (Chang et al., 2015). Moreover, by introdu-
cing several gRNAs, multiplex genome editing is possible to dis-
rupt multiple genes or delete a large fragment of genomic region
located on the same chromosome (Jao et al., 2013; Ota et al., 2014).
In addition, CRISPR interference (CRISPRi) using nuclease-deﬁcient
Cas9 (dCas9) has been developed for blocking initial transcription
or transcriptional elongation instead of disrupting genomic se-
quences (Larson et al., 2013). Furthermore, by fusing dCas9 to a
transcriptional activator or repressor, one can artiﬁcially activate
or repress target gene transcription (Gilbert et al., 2013). These
various applications of CRISPR/Cas9 systems have opened up op-
portunities to uncover developmental mechanisms encoded in
genomes.
Sea urchin is a suitable model system for studying early de-
velopmental mechanisms, due to the simple organization of its
embryo and its amenability to experimental manipulations
(McClay, 2011). The sequenced genome and rich transcriptomic
data also serve as excellent resources for understanding the gene
regulatory networks underlying various developmental processes,
including cell speciﬁcation and morphogenesis (Sea Urchin Gen-
ome Sequencing et al., 2006; Tu et al., 2012). Perturbations of gene
function in sea urchin embryos mostly rely on injection of MOs
that block translation or splicing of gene transcripts of interest.
However, assessing the speciﬁcity of MOs is a common problem
and off-target effects have been found in sea urchin embryos in-
jected with MOs (Coffman et al., 2004).
In recent years, ZFN and TALEN technologies have been used in
sea urchin embryos to knockout developmental genes (Hosoi et al.,
2014; Ochiai et al., 2010). However, only 10% of ZFN- or TALEN-
injected embryos showed the corresponding phenotype. Here, we
assessed the efﬁciency of the CRISPR/Cas9 system in sea urchin
embryos, and compared its effects to that of the gene-speciﬁc MO.
We chose the nodal gene as the target because it is zygotically
expressed during early embryogenesis and its knockdown phe-
notype is readily observed due to its important role in dorsoven-
tral patterning in sea urchin embryos (Duboc et al., 2004; Su et al.,
2009). Nodal is a member of the Transforming Growth Factor beta
(TGFβ) superfamily, and knockdown of Nodal by MOs disrupts the
dorsoventral axis and radializes the embryos (Duboc et al., 2004).
In this study, we designed six Nodal gRNAs, and found that ﬁve
of them were able to efﬁciently knockout Nodal in sea urchin
embryos. Around 60–80% of the injected embryos showed the
same phenotype as that of the MO-injected or Nodal inhibitor-
treated embryos. CRISPR/Cas9-mediated indels were found in the
nodal gene, but not in the potential off-target sites. These dataindicate that CRISPR/Cas9 technology can be used in sea urchin
embryos to efﬁciently and speciﬁcally induce mutations.2. Materials and methods
2.1. Sea urchins and embryos
Adult sea urchins (Strongylocentrotus purpuratus) and their
gametes were obtained as previously described (Luo and Su, 2012).
In vitro fertilization and embryo culture were performed at 14 °C in
ﬁltered seawater.
2.2. Preparation of the gRNAs
The 18–20 bp target sequences of the candidate gRNAs were
designed using the ZiFiT online tool (http://ziﬁt.partners.org/ZiFiT/
) (Sander et al., 2010; Sander et al., 2007). This target sequence
contains two guanine nucleotides at the 5′ end, while its 3′ end is
adjacent to an NGG motif (PAM) in the nodal gene (Fig. S1A–B). To
identify the potential off-target sites, the seed region (12-bp of the
3′ end of the target sequence) plus NGG was used to blast the sea
urchin genome at EchinoBase (http://www.echinobase.org/Echi
nobase/) (Cameron et al., 2009) (Fig. S1C). Candidate gRNAs with
relatively high GC content and few potential off-target sites were
selected and synthesized. One sense and one antisense oligonu-
cleotide were designed based on the target sequence. To create 5′
overhangs for ease of cloning, TA and AAAC nucleotides were ad-
ded to the 5′ end of the sense and antisense oligonucleotide, re-
spectively. The oligonucleotidess were annealed by heating the
mixture to 95 °C and then cooling it down to room temperature in
a 1x NEB#2 buffer (New England Biolabs). Annealed oligonucleo-
tides were subsequently cloned into a BsmBI (NEB)-digested pT7-
gRNA vector (Addgene) at a site that is downstream of a T7 pro-
moter (Fig. S1D).
2.3. Microinjection and drug treatment
Templates for in vitro gRNA synthesis were prepared by line-
arization of the plasmid DNA or PCR ampliﬁcation. For the line-
arization method, pT7-gRNA vectors containing gRNAs were line-
arized with BamHI (NEB). For the PCR method, the fragments
containing the full gRNA sequence followed by the T7 promoter
were ampliﬁed using PCR with speciﬁc primer pair for 30 cycles
(Table S1). We noted that the concentrations of gRNAs synthesized
using the PCR method are more consistent between the mea-
surements of spectrophotometry and gel electrophoresis. Six
gRNAs against the nodal gene of S. purpuratus (SpNodal) were in
vitro synthesized using a MEGAshortscript T7 Transcription Kit
(Life Technologies). The quantities of the synthesized gRNAs were
examined by gel electrophoresis and spectrophotometry. pCS2-
nCas9n vector was linearized with NotI (NEB). Capped nls-Cas9-nls
mRNA was in vitro synthesized using a MEGAscript SP6 Tran-
scription Kit (Life Technologies). Embryos were injected with a
mixture of the gRNA and Cas9 mRNA (Fig. S1E) or SpNodal MO
(TGCATGGTTAAAAGTCCTTAAAAAT, Gene Tools) at 100 μM. Nodal
signaling inhibitor SB431542 (1.5 μM) was added after
fertilization.
2.4. Preparation of genomic DNA
Embryos were incubated individually or in bulk (ﬁve or twenty
embryos; mixed) in 1 μl or 8 μl of lysis buffer (1x NEB#2 buffer,
New England Biolabs), respectively at 94 °C for 10 min, and then
cooled down to 4 °C for 10 min. A volume of 0.5 μl of proteinase K
(5 mg/ml) for the individual embryo or 1 μl of proteinase K
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were then incubated at 55 °C for 2 h. Finally, the samples were
boiled at 94 °C for 10 min to inactivate proteinase K, and the so-
lution was diluted 2-5-folds for use in PCR.
2.5. Heteroduplex mobility assay (HMA) and sequencing
DNA fragments containing gRNA target sequences (nodal exon
1, 5′ region of exon 2, or 3′ region of exon 2) were ampliﬁed by PCR
using the KAPA HIFI or Bioman 2X mix DNA polymerase with
speciﬁc primer pairs. PCR primers used in this study are listed in
Table S1. The PCR amplicons were reannealed and subsequently
electrophoresed on a commercial automated electrophoresis sys-
tem, LabChip, using a standard protocol (PerkinElmer). To examine
indels in embryos injected with gRNA and Cas9 mRNA, DNA
fragments from different embryos were cloned individually into
the pGEM-T Easy vector (Promega). Bacterial colonies were ran-
domly selected for plasmid DNA extraction and sequencing (Fig.
S1F).
2.6. In situ hybridization
Embryos were ﬁxed in 4% paraformaldehyde overnight at 4 °C,
and then subjected to whole mount in situ hybridization using
digoxigenin-labeled antisense RNA probes with an alkaline phos-
phatase-conjugated anti-digoxigenin antibody, as previously de-
scribed (Luo and Su, 2012). All images were taken using a Zeiss
AxioCam MRC camera mounted on a Zeiss Imager A2 microscope.3. Results
3.1. CRISPR/Cas9-mediated genome editing of the nodal gene pro-
duced a radialized phenotype
SpNodal is encoded by two exons (Fig. 1A), with the TGFβ-
propeptide domain encoded by both exons and the TGFβ domain
encoded by exon 2 (Fig. 1B). Consideration of gRNA size, GC con-
tent, and the number of potential off-targets led us to design sixFig. 1. Positions and sequences of gRNAs targeting the nodal gene. (A) A schematic
representation of the nodal locus and the positions of the six gRNAs. The arrows
indicate the orientation of the gRNAs. (B) A schematic representation of the protein
domain organization of Nodal. (C) When designing gRNAs, several parameters were
taken into consideration, including the length of the target sequence, the percen-
tage of GC content, and number of potential off-target sites. The seed regions of the
gRNA target sequences are shown in red font.gRNAs against the nodal gene: three were directed against exon 1
(E1-123, E1-157, and E1-272) and the other three against exon 2
(E2-63, E2-777, and E2-885) (Fig. 1C). To test the toxicity of Cas9
endonuclease, we injected zygotes with different amount of Cas9
mRNA in combination with randomly selected gRNAs synthesized
using the linearlization method at different ratios. At 24 hours
post-fertilization (hpf), many embryos injected with higher do-
sages of Cas9 mRNA (41500 ng/μl) were dead or exhibited severe
developmental delay (Fig. S2). Embryos injected with lower
amounts of Cas9 mRNA combined with various concentrations of
gRNA developed into normal mesenchyme blastulae by 24 hpf. A
thorough test combining either of the two concentrations of Cas9
(750 or 150 ng/μl) with different amount of one of the six gRNAs
(5:1 or 25:1) synthesized by the PCR method was then performed.
We examined the phenotypes of these embryos at the gastrula
stage (48 hpf), when the dorsoventral axis is morphologically
distinguishable. In wild type gastrula, the archenteron bends to-
ward the ventral side, and the spicules are formed at the two
ventral lateral clusters of the skeletogenic cells. In most embryos
injected with 750 ng/μl of Cas9 mRNA and 150 ng/μl of E1-157, E1-
272, E2-63, E2-777, or E2-885 gRNA, gastrulation proceeded nor-
mally, but the archenteron did not bend toward the ventral side,
and skeletogenesis occurred at multiple places (Fig. 2A), which is
the typical radialized phenotype of the nodal morphants (Duboc
et al., 2004). In embryos injected with Cas9 and E1-123 gRNA, the
dorsoventral patterning was not affected and the embryos devel-
oped into normal pluteus larvae at 72 hpf (Fig. 2B). The percen-
tages of radialized embryos upon injection of Cas9 and gRNA at
different concentrations and ratios were examined at 48 hpf and
summarized in Fig. 2C. The ﬁve effective gRNAs caused radializa-
tion in 65–97% of the injected embryos when injected at 150 ng/μl
(with 750 ng/μl Cas9) (Table 1). Except E1-157, which was effective
in causing radialization phenotype in all the concentrations/ratios
we examined, the percentages of the radialized embryos were
reduced when the injected amounts of gRNAs and Cas9 were de-
creased. More biological replicates were performed to demon-
strate that, on average, 82% and 81% of the embryos injected with
E1-157 and E1-272 at 150 ng/μl (with 750 ng/μl Cas9), respec-
tively, showed the radialized phenotype (Table S2).
3.2. Genotyping of embryos injected with Cas9/gRNA revealed that
genome editing was highly efﬁcient
Three methods are commonly used to rapidly screen for
CRISPR/Cas9-mediated genome editing: T7 endonuclease I (T7E1)
assay, high resolution melt (HRM) analysis, and heteroduplex
mobility assay (HMA) (Hwang et al., 2013; Ota et al., 2014; Thomas
et al., 2014). T7 endonuclease I recognizes and cleaves mismatched
DNA when even a single base is mismatched. Because the sea
urchin genome exhibits high heterozygosity (1–5% single nucleo-
tide polymorphism (SNP) plus indel) (Sea Urchin Genome Se-
quencing et al., 2006), the T7E1 assay may generate false-positive
results. HRM analysis requires a sufﬁcient amount of DNA mate-
rials for detection after ampliﬁcation. When DNA from a single sea
urchin embryo was ampliﬁed following a standard protocol, no
signal was detected (data not shown). HMA is a fast and efﬁcient
method for determining the difference between heteroduplex and
homoduplex DNA (Ota et al., 2014). Electrophoresis of DNA con-
taining deletions of more than 2 base pairs on a 15% acrylamide gel
reveals a heteroduplex band that is at a different position com-
pared to that of a homoduplex. When DNA contains multiple in-
dels, multiple heteroduplexes can be detected as smeared bands.
To precisely link phenotype with genotype, we conducted
genotyping of individual embryos injected with Cas9 mRNA and
gRNA. Isolation of genomic DNA from a single embryo for geno-
typing is routinely performed with zebraﬁsh embryos (Hwang
Fig. 2. Five of the six gRNAs were able to radialize the embryos. (A) Embryo morphology was observed at the gastrula stage from the lateral side (upper panels) or vegetal
pole (lower panels) under differential interference contrast (DIC) upon injection of Cas9 and gRNA as indicated. (B) A Cas9/E123-injected embryo was observed at the pluteus
stage from the lateral side. (C) Percentages of radialized embryos upon injection of Cas9 and either one of the gRNAs at different concentrations and ratios as indicated.
Table 1
Phenotypic ratios of embryos injected with Cas9 mRNA (750 or 150 ng/μl) and one
of the six gRNAs (5:1 or 25:1) scored at the gastrula stage.
gRNAs Cas9/gRNA Radialized WT-like Total
(ng/μl) % (n) % (n) n
E1-123 750/150 0 (0) 100 (45) 45
750/30 0 (0) 100 (40) 40
150/30 0 (0) 100 (28) 28
150/6 0 (0) 100 (18) 18
E1-157 750/150 76 (26) 24 (8) 34
750/30 82 (36) 18 (8) 44
150/30 68 (15) 32 (7) 22
150/6 81 (29) 19 (7) 36
E1-272 750/150 65 (45) 35 (24) 69
750/30 2 (1) 98 (47) 48
150/30 0 (0) 100 (31) 31
150/6 0 (0) 100 (42) 42
E2-63 750/150 97 (32) 3 (1) 33
750/30 71 (25) 29 (10) 35
150/30 24 (4) 76 (13) 17
150/6 9 (2) 91 (21) 23
E2-777 750/150 83 (30) 17 (6) 36
750/30 3 (1) 97 (31) 32
150/30 0 (0) 100 (37) 37
150/6 0 (0) 100 (42) 42
E2-885 750/150 86 (42) 14 (7) 49
750/30 64 (37) 36 (21) 58
150/30 12 (5) 88 (36) 41
150/6 0 (0) 100 (37) 37
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and low cell numbers have made it difﬁcult to perform single
embryo genotyping with sea urchin embryos; as such, previous
studies collectively genotyped batches of 40–400 sea urchin em-
bryos perturbed with ZFN or TALENs (Hosoi et al., 2014; Ochiai
et al., 2010). To overcome this problem, we modiﬁed the genomicDNA isolation method. First, we directly lyzed individual embryos,
instead of using a DNA extraction method. Second, we reduced the
amount of lysis buffer used to lyse a single sea urchin embryo prior
to proteinase K treatment. Finally, we prepared a 5-fold dilution of
the lysed embryo for PCR (4–5 reactions per injected embryo).
We performed HMA for genotyping individual or bulk injected
embryos after the DNA fragments encompassing the gRNA target
sites were ampliﬁed by PCR. In wild type embryos, a distinct band
of the correct size is clearly visible in the gel (Fig. 3). This band
represents the homoduplex, and is also seen in embryos injected
with the ineffective E1-123 gRNA/Cas9. In bulk analyses of em-
bryos injected with either one of the ﬁve effective gRNAs (mixed,
n¼5), smeared bands representing multiple heteroduplexes are
observed, and no single band is dominant over the others in most
cases (Fig. 3A). These results correlate well with the observed
phenotype: the embryos were radialized by the effective gRNAs,
but not E1-123. We further examined the PCR amplicons from
individual embryos that exhibited a radialized phenotype. HMA
revealed that a single embryo injected with either E1-157 or E1-
272 exhibited a more distinct heteroduplex band (Fig. 3B). These
results strongly suggest that injection of either one of the effective
gRNAs generated indels within the nodal gene.
To examine the indels induced by CRISPR/Cas9-mediated gen-
ome editing, we cloned the PCR amplicons from the injected
embryos that displayed the radialized phenotype into the pGEM-T
easy vector for sequencing. For all the effective gRNAs, we ob-
served a large proportion of clones containing indels at the ex-
pected gRNA target sites (Fig. 4). Consistently, the ineffective E1-
123 did not cause indels around its target site. Among 41 se-
quenced clones from embryos injected with any one of the effec-
tive gRNAs, we observed insertion (3 clones; 7%), deletion (21
clones; 51%), and indel (11 clones; 26%). The mutation rate ranged
from 66% to 100% and the average was 85%. The high proportion of
Fig. 3. Genotyping using the Heteroduplex mobility assay (HMA). PCR amplicons from exon 1 were obtained from mixed embryos (A) or a single embryo (B) and elec-
trophoresed in an automated electrophoresis system. (C) Another set of primers against exon 1 was used to conﬁrm the formation of multiple heteroduplexes. (D and E) PCR
amplicons from exon 2 were electrophoresed. Embryos were wild-type (WT) or injected with the indicated gRNA/Cas9. The sizes (bp) of the marker DNAs are indicated on
the sides of the gels.
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and efﬁciently during sea urchin embryogenesis, and that most
cells in the embryo carry the mutations. We next examined when
the genome editing occurred during sea urchin embryogenesis.
HMA analyses were performed on samples collected every four to
six hours from 4 hpf to 24 hpf. We found that heteroduplexes were
detected at 4 hpf (8-cell stage) for E1-157 and 12 hpf (early blas-
tula stage) for E1-272 (Fig. 5), suggesting that the mutations were
introduced early during cleavage stages.Fig. 4. Indels of embryos revealed by sequencing. The embryos are injected with Cas9
rounding the target sequence are shown. The wild-type (WT) sequence from Echinobase
protospacer adjacent motif (PAM) are shaded in blue and red, respectively. PCR amplicon
same sample are grouped in brackets. The ratios of clones containing indels to total clone
shown in blue and red fonts, respectively. The numbers of indels in each sequence wer3.3. Nodal CRISPR/Cas9, similar to Nodal MO and Nodal signaling
inhibitor, regulated the expression of Nodal downstream genes
In sea urchin embryos, Nodal signaling activates a group of
genes in the prospective oral ectoderm at the blastula stage before
the dorsoventral axis is morphologically recognizable (Duboc
et al., 2004; Su et al., 2009). Here we investigated the expression of
nodal downstream genes, nodal itself, and chordin in nodal gRNA/
Cas9-injected embryos at the mesenchyme blastula stage. Weand either one of the gRNAs as indicated. Alignments of the DNA fragments sur-
(Sp genome 3.1) is on the ﬁrst row from the top. The gRNA target sequences and the
s from individual or mixed radialized embryos were sequenced. Sequences from the
s are shown on the left side of each group. The inserted and deleted nucleotides are
e counted, as shown on the right side of each row.
Fig. 5. Examination of the timing of genome editing. Cas9 and E1-157 or E1-272 gRNA-injected embryos were collected at 4, 8, 12, 18 and 24 hpf and analyzed by HMA. The
number of the embryos used for HMA is indicated in the bottom of each lane.
Fig. 6. Expression of the nodal, chordin, and onecut genes in nodal knockout or knockdown embryos. In situ hybridization analyses were performed in wild-type, Cas9 and E1-
157- or E1-272-injected, nodal MO-injected, or SB431542-treated embryos. The ratios of the displayed phenotypes to total embryos are indicated in the bottom right-hand
corner of each panel.
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or E1-272-injected embryos, which was also observed for Nodal
MO-injected and SB431542-treated embryos (Fig. 6). Nodal MO
also caused ectopic expression of the ciliary band marker onecut at
the gastrula stage (Saudemont et al., 2010), and the same effect
was observed in E1-157-, E1-272-injected, or SB431542-treated
embryos (Fig. 6). These results conﬁrm that the radialized phe-
notype arises from disruption of Nodal function. We proceeded to
sequence the nodal gene of E1-157- or E1-272-injected embryos
in which chordin expression could not be detected using in situ
hybridization. Similar to the previous results, 86.4% (19/22)
of the clones were found to contain indels in the nodal gene
(Fig. S3).3.4. Off-target effects were not observed in the examined potential
off-target sites
The CRISPR/Cas9 system is a highly efﬁcient tool for genomic
editing. Nevertheless, its applicability is limited by the potential
off-target binding. Several web-based online tools can be used to
predict off-target binding sites. However, the sea urchin genome
has not been incorporated into these tools. Therefore, we per-
formed BLAST searches directly against the genome using the
EchinoBase online tool. Previous studies have shown that a 12-bp
seed region of a gRNA adjacent to the PAM site is more important
than the rest of the target sequence for speciﬁc binding (Jiang
et al., 2013; Larson et al., 2013). We used the 12-bp seed regions of
Fig. 7. Genome editing events are not detected at the potential off-target sites. Alignments of the DNA fragments surrounding the E1-157 (A) or E1-272 (B) off-target sites.
One of the E1-157 off-target sites is located in an exon of the gamma-aminobutyric acid receptor subunit beta-1 gene. The gRNA target sequences and PAM are highlighted
with green and red backgrounds, respectively. The mismatched nucleotides are shown in red font.
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urchin genome for potential off-target sites. In addition to the on-
target site, the seed regions of both E1-157 and E1-272 gRNAs
mapped to two additional sites. One of the off-target sites pre-
dicted for E1-157 gRNA is located in the exon region of the gamma-
aminobutyric acid receptor subunit beta-1 gene. Sequencing of this
gene using DNA isolated from E1-157 gRNA/Cas9-injected em-
bryos revealed that no genomic editing occurred in this region
(Fig. 7A). Similarly, genome editing was not observed at one of the
E1-272 gRNA off-target sites located in the non-coding region, as
determined by sequencing of DNA from E1-272 gRNA/Cas9-in-
jected embryos (Fig. 7B). We noticed that the PAM sequence of this
predicted off-target site in the published sea urchin genome was
not present in all of the sequenced clones, conﬁrming that the sea
urchin genome has high heterozygosity.4. Discussion
In this study, we successfully disrupted the nodal gene in the
sea urchin embryo using the CRISPR/Cas9 system. To increase the
efﬁciency of mutation, we used a modiﬁed CRISPR/Cas9 system
consisting of a nucleus localization signal (NLS)-fused Cas9 and a
gRNA with residues GGAUC at the 3′ end (Jao et al., 2013). Of the
six gRNAs designed to target the nodal gene, we found that ﬁve
were able to speciﬁcally and efﬁciently disrupt the sea urchin
genome. The efﬁciency ratio (83.3%) is higher than that reported
for the ascidian Ciona intestinalis (25%; 2 out of 8 gRNAs) (Sasaki
et al., 2014), zebraﬁsh (80%; 8 out of 10 gRNAs) (Hwang et al.,
2013), and Drosophila (75%; 3 out of 4 gRNAs) (Bassett et al., 2013).
However, it remains possible that the high efﬁciency is special to
the nodal gene. Nevertheless, it has been shown that the nucleo-
tide compositions of gRNAs are more relevant to their efﬁciencies;
guanine enrichment and adenine depletion increase the stability
and activity of gRNAs (Moreno-Mateos et al., 2015). gRNAs con-
taining a guanine adjacent to the PAM site also results in higher
cleavage efﬁciencies (Doench et al., 2014; Gagnon et al., 2014). We
are currently investigating the efﬁciencies of the CRISPR/Cas9
system targeting to other sea urchin genes.
Use of the same CRISPR/Cas9 system in zebraﬁsh embryos re-
sulted in a 75–99% mutation rate and visible F0 phenotypes, due to
highly efﬁcient biallelic genomic modiﬁcation (Jao et al., 2013). In
the sea urchin embryo, we observed that except E1-123, the ﬁve
effective gRNAs caused mutation rates ranging from 66% to 100%.
The efﬁciency of the CRISPR/Cas9 system in sea urchin embryos is
comparable to that in zebraﬁsh embryos, and much higher than
that of ZFN and TALEN in sea urchin embryos (44–51.9%) (Hosoi
et al., 2014; Ochiai et al., 2010). The corresponding phenotypes
were observed in only 9.5% and 12.6% of the ZFN- and TALEN-in-
jected embryos, respectively. The lower proportion of phenotypi-
cal changes as compared to genotypical changes may indicate that
only a single allele was disrupted in most cells by ZFN and TALENs.In our study, we observed a high proportion of injected F0 em-
bryos with a radialized phenotype, suggesting that the CRISPR/
Cas9 system efﬁciently induces biallelic genomic modiﬁcations in
sea urchin embryos.
Previous studies have shown that in sea urchin embryos, ZFN-
mediated mutagenesis was weakly detected at the 8-cell stage and
the mutations introduced by TALEN was not observed until the
morula stage (Hosoi et al., 2014; Ochiai et al., 2010). In our study,
we discovered that mutations were detected in embryos injected
with Cas9 and E1-157 or E1-272 gRNA at the 8-cell or early blas-
tula stage, respectively. Therefore, the timings of genome editing
are comparable among the three tools. Different indels observed in
a single Cas9/gRNA injected embryo (Fig. 4) also supports that
mutations occurred independently in different cells/alleles. Given
that mutations are introduced during cleavage stages, it is possible
that not all cells in an embryo carry the mutations. Indeed, we
observed that half of the sequenced clones from one embryo in-
jected with Cas9/E1-157 were not mutated. The fact that the em-
bryo still showed the radialized phenotype suggests that the cells
that carry the mutations are located on the oral side of the em-
bryo. On the other hand, embryos displaying normal phenotype
may still carry mutations in cells that normally do not express
nodal. To accelerate the timing of genome editing and overcome
the mosaic property, injection of Cas9 protein may be used to
bypass the translation of the capped Cas9 mRNA (Fujii et al., 2015;
Gagnon et al., 2014).
Off-target effects are a major concern for sequence-speciﬁc
knockdown/knockout technologies, such as MO and CRISPR/Cas9.
Given the increasing availability of sequenced genomes, it is often
possible to predict and avoid potential off-targets when designing
MOs or gRNAs. However, the BLAST-based algorithms may not be
able to predict all potential off-target sites. A recent study used an
unbiased genome-wide proﬁling analysis and discovered several
off-targets that are not predicted by blast searches (Tsai et al.,
2015). We thus cannot rule out the possibility that the gRNAs used
in this study have no off-target effects. Unbiased approaches or
RNA rescued experiments will need to be performed to test the
speciﬁcity of the CRISPR/Cas9 system. In addition, concerns re-
garding morphants and mutants remain high because in many
cases morphant phenotypes are not the same as the mutant
phenotypes (Kok et al., 2015). It has been shown recently that
deleterious mutations may result in the activation of a compen-
satory network that is not observed after translational knockdown
by MOs (Rossi et al., 2015). It is thus important to combine several
genetic tools and compare phenotypes to correctly decipher gene
functions.
The CRISPR/Cas9 system described in this study is a highly ef-
fective tool for genome editing in sea urchin embryos. In addition,
we developed a simple procedure to genotype individual sea
urchin embryos, thereby enabling phenotype to be precisely linked
with genotype. This procedure applies not only to live embryos,
but also to ﬁxed embryos following in situ hybridization analysis.
C.-Y. Lin, Y.-H. Su / Developmental Biology 409 (2016) 420–428 427The CRISPR/Cas9 system and single embryo genotyping technique
promise to be of considerable beneﬁt to studies of developmental
mechanisms and gene regulatory networks in sea urchin.Acknowledgement
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